Korsana Biosciences (KRSA) Stock Analysis
NASDAQHealthcareBiotechnology
Track KRSA in your portfolio for free · Portfolio tracker
What Korsana Biosciences does
Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. Its product pipeline includes several sGC stimulators, small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate. The company was founded on September 6, 2018 and is headquartered in Cambridge, MA.
Key metrics
ETFs linked to KRSA
Broad-market and Healthcare sector ETFs an investor holding Korsana Biosciences is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how KRSA fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze KRSA in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Korsana Biosciences?
- Korsana Biosciences trades under the ticker KRSA on NASDAQ.
- Which exchange is KRSA listed on?
- KRSA is listed on NASDAQ.
- What sector does Korsana Biosciences operate in?
- Korsana Biosciences is classified in the Healthcare sector (Biotechnology industry).
- How can PortView help analyze KRSA in a portfolio?
- PortView shows KRSA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.